Efficacy of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective, 24-week, open-label phase Mb/IV clinical trial in patients from Latin America

被引：0
|
作者：
Stengel, Fernando M. [1 ]
Chouela, Edgardo [2 ]
Takahashi, Maria Denise Fonseca [3 ]
Amaya, Mario [4 ]
机构：
[1] Inst Univ Cemic, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Hosp Cosme Argerich, RA-1053 Buenos Aires, DF, Argentina
[3] Univ Sao Paulo, Hosp Clin, Fac Med, BR-05508 Sao Paulo, Brazil
[4] Hosp Especial, IMSS, Monterrey, NL, Mexico
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB133 / AB133
页数：1
相关论文
共 50 条
  • [1] Safety of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America
    Chouela, Edgardo
    Martins, Gladys Aires
    Cestari, Tania E.
    Hernandez, Maria Eugenia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB134 - AB134
  • [2] Efficacy and safety of efalizumab in adults with moderate to severe plaque psoriasis and hand and foot involvement: A prospective, 24-week, open-label phase IIIb/Iv clinical trial in patients from Latin America
    Cardenas, Engracia Lopez
    de Arruda, Lucia Favora
    Abulatia, Luna Azulay
    Gonzalez, Virgilio Santamaria
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB131 - AB131
  • [3] Efficacy and safety of efalizumab for scalp psoriasis: Results from a prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America
    Takahashi, Maria Denise Fonseca
    Oliveira, Maria de Fatima
    Paramo, Antonio Vera
    Stengel, Fernando M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB134 - AB134
  • [4] A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results
    Magnolo, Nina
    Kingo, Kulli
    Laquer, Vivian
    Browning, John
    Reich, Adam
    Szepietowski, Jacek C.
    Keefe, Deborah
    Mazur, Rafal
    Ghelani, Prayashi
    Forrer, Pascal
    Wraith, LindaAnn
    Patekar, Manmath
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 122 - 130
  • [5] Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)
    Esteban Daudén
    Pablo de la Cueva
    Laura Salgado-Boquete
    Mar Llamas-Velasco
    Eduardo Fonseca
    Ignasi Pau-Charles
    David Asensio
    Meritxell Guilà
    José Manuel Carrascosa
    Dermatology and Therapy, 2023, 13 : 329 - 345
  • [6] Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)
    Dauden, Esteban
    de la Cueva, Pablo
    Salgado-Boquete, Laura
    Llamas-Velasco, Mar
    Fonseca, Eduardo
    Pau-Charles, Ignasi
    Asensio, David
    Guila, Meritxell
    Manuel Carrascosa, Jose
    DERMATOLOGY AND THERAPY, 2023, 13 (01) : 329 - 345
  • [7] Safety of efalizumab therapy in patients with moderate to severe psoriasis - An open-label extension of a phase IIIb trial
    Hamilton, Tiffani
    Menter, Alan
    Caro, Ivor
    Compton, Peter
    Sobell, Jeffrey
    Papp, Kim A.
    DRUG SAFETY, 2008, 31 (08) : 715 - 726
  • [8] Safety and tolerability of efalizumab therapy for patients with moderate to severe chronic plaque psoriasis: Results of an open-label phase IIIB multicenter trial
    Menter, A
    Hamilton, T
    Papp, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P195 - P195
  • [9] Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients with Moderate-to-Severe Plaque Psoriasis: 24-Week Data from a Phase 3 Trial
    Ghislain, Pierre-Dominique
    Conrad, Curdin
    Dutronc, Yves
    Henneges, Carsten
    Calderon, David Sandoval
    Vincent, Myriam
    Ghys, Liesbet
    de Gruijter, Jolien
    van de Kerkhof, Peter C. M.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] An open-label, multicentre, 24-week, exploratory study to assess the efficacy and safety of dimethyl fumarate in patients with moderate plaque psoriasis: patient baseline characteristics
    Warren, R. B.
    Atwan, A.
    Skov, L.
    Cooper, H.
    Pink, A.
    Foulkes, A. C.
    Kirby, B.
    Everiss, T.
    Pau-Charles, I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E92 - E93
12345